Insights

On August 4, 2025, the Ninth Circuit Court of Appeals held that an employer cannot unilaterally impose arbitration provisions on plan participants through plan amendments. Specifically, the court held that employers cannot bind participants to arbitrate ERISA claims without their express consent and that the plaintiff in the case had not agreed to arbitrate ERISA claims as required under the Federal Arbitration Act (FAA). Background The plaintiff in the case, Robert Platt, brought an ERISA clas

On June 20, 2025, Gov. Abbott signed SB 2544 into law. The law established a 180-day deadline for out-of-network providers and health plan issuers or administrators to request mediation in a balance billing dispute. Under Texas law, out-of-network providers must follow a mediation process established by the Texas Department of Insurance (TDI) to resolve billing disputes with plans regulated by the state (or self-insured plans that opted into the process). The law imposes this requirement on ful

Workplace diversity is a complex legal balancing act, and the rise in reverse discrimination lawsuits signals that DEI backlash is no longer cultural — it is becoming a matter of law.

Join NFP experts as they unpack OBBBA’s impact on HSAs, PFML, DCAP, telehealth, Medicaid, ACA Marketplaces, and more for employers.

As federal enforcement of I-9 compliance increases, it's more important than ever for employers to stay vigilant and in compliance with immigration law.

Learn how to address pharmacy deserts and protect employee health, equity and costs as closures rise across urban, suburban and rural areas.

Explore how trade policy shapes drug pricing and pharmacy access, and what shifting tariffs mean for patients, supply chains and future care costs.

GLP-1 (glucagon-like peptide) medications like Ozempic and Wegovy have continued growing in popularity over the last several years.

Discover how GLP-1 access is shifting with compounding bans, DTC pharmacy growth and new coverage rules reshaping patient care and employer strategy.